FDA Adverse Event Injury Summary report: N

VOLIFT (VOLUME UNKNOWN)

MDR report key: 25231798 · Received May 20, 2026

Report

Report Number
3005113652-2026-00496
Event Type
Injury
Date Received
May 20, 2026
Date of Event
April 10, 2026
Report Date
May 20, 2026
Manufacturer
PRINGY
Product Code
LMH
PMA / PMN Number
P110033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CLARIFICATION TO H.6. TYPE OF INVESTIGATION CODE: THE FILLER WAS INJECTED INTO THE PATIENT AND IS NOT ACCESSIBLE FOR RETURN. THE SYRINGE WAS NOT RETURNED FOR EVALUATION. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ABBVIE IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THE REPORTER HAS DECLINED TO PROVIDE ABBVIE FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED INJECTING A PATIENT IN THE LOWER PART OF THE FACE WITH 1 ML OF JUVÉDERM® VOLIFT® WITH LIDOCAINE, 1 ML OF JUVÉDERM® VOLUX¿, AND 1 ML OF JUVÉDERM® VOLUMA¿ WITH LIDOCAINE. FOUR MONTHS LATER, THE PATIENT WAS INJECTED IN THE PREAURICULAR AREA AND MARIONETTE LINES WITH 1 ML OF JUVÉDERM® VOLUMA¿ WITH LIDOCAINE AND IN THE NASOLABIAL FOLDS WITH 1 ML OF JUVÉDERM® VOLIFT® WITH LIDOCAINE. SEVENTEEN DAYS LATER, THE PATIENT EXPERIENCED ¿EDEMA AND ERYTHEMA¿ IN THE CHIN AREA THAT WAS TREATED WITH A MEDROL DOSEPAK WITH GOOD RESULTS. HOWEVER, 12 DAYS LATER, THE PATIENT EXPERIENCED ¿PAIN¿ WHEN CHEWING. THE PATIENT WAS TREATED WITH AUGMENTIN WITHOUT EFFECT. EVENT WAS ONGOING. THIS FILE CAPTURED THE ADDITIONAL JUVÉDERM® VOLIFT® WITH LIDOCAINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
108205 VOLIFT (VOLUME UNKNOWN) IMPLANT, DERMAL, FOR AESTHETIC USE LMH PRINGY NI

Patients

Seq Age Sex Outcome Treatment
1 57 YR Female Required Intervention